From April 25 to 30, 2025, the American Association for Cancer Research (AACR) Annual Meeting was held in Chicago. At this prestigious event, the research team led by Dr. Fang Wu from the Cancer Center of the Second Xiangya Hospital of Central South University, presented their study titled “Neoadjuvant EGFR-TKI therapy reshapes tumor immune microenvironment in resectable EGFR-positive non-small cell lung cancer” as a poster presentation.
